These analyses showed that COL10A1 was involved in regulating the immunity of the tumor microenvironment in BLCA, especially in CD4+T cells, CD8+T cells, and M2 macrophages. The gene discussed is COL10A1; the disease is bladder transitional cell carcinoma.